Searched for
INDIAN IMMUNOLOGICALS LTD
Rabies vaccine row: CDSCO flags seized Abhayrab batch was misbranded, 4 arrested after media reportA seized batch of rabies vaccine Abhayrab was found misbranded and not of standard quality. Delhi Police arrested four people in connection...
Govt flags Abhayrab rabies vaccine batch as substandard, probes if spurious, document showsIndia's drug regulator has flagged a batch of Abhayrab rabies vaccine as substandard. This finding marks the second time concerns have been...
Picking the right pharma stock is getting harder; so pick a portfolio: 20 stocks with -23% to +22% downside to upside potentialFor Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...
Japan's Takeda bets on dengue vax to reshape India playbookTakeda Pharmaceutical's new dengue vaccine Qdenga received approval in India. The vaccine is expected to launch commercially in early 2027....
ChrysCapital acquires controlling 70.68% stake in Novartis India listed unit in first majority pharma investmentChrysCapital has acquired a controlling interest in Novartis India Limited, representing its inaugural investment in India's pharmaceutical...
10,000-year-old disease that haunted Greeks and Chinese, weakened Civil War soldiers and caused 5% of 20th century deaths may finally have a weakness; Indian researchers find breakthroughScientists from India and Britain have identified a protein called Ark1 that acts as a control switch in the malaria parasite's cell divisi...
Japanese drugmaker Takeda's Qdenga becomes first dengue vaccine approved in IndiaIndia's drug regulator has approved Takeda's Qdenga dengue vaccine, the first of its kind. This vaccine is expected to become available in ...
Veterinary vaccine firms form association for collaboration with policymakersIndia's leading veterinary vaccine manufacturers, including Hester Biosciences and Indian Immunologicals, have formed the Veterinary Vaccin...
Indian Immunologicals targets dengue vaccine launch by January 2026Vaccine manufacturer Indian Immunologicals Limited (IIL) expects to commercially launch its dengue fever vaccine by early 2026, a top execu...
IIL to make 10 million doses of Covaxin drug substance from DecemberIndian Immunologicals' Managing Director K Anand Kumar informed that IIL is also working on an attenuated COVID-19 vaccine which is likely ...
State-owned BIBCOL set to begin production of Bharat Bio's Covaxin by February 2022The government is now betting on Indian Immunologicals to boost Covaxin production this year as Haffkine Bio-Pharma managing director Sande...
IIL set to expand its protozoan Vaccine portfolioInstituto Nacional de Tecnologia Agropecuaria (INTA) is Argentina’s federal agency in charge of the generation, adaptation and diffusion of...
NDDB-arm develops world’s first vaccine against tapeworms in pigsIIL has obtained the license the to manufacture and market the vaccine after conducting extensive field trials in India and many other coun...
Indian Immunologicals to unveil feed for lab animals used for clinical trialsAt present, India houses hundreds of scientific bodies, both in public and private sectors, which together have nearly 10 million lab anima...
Indian Immunologicals plans Rs 300 crore vaccine plant in PondicherryHyderabad headquartered vaccine manufacturer Indian Immunologicals Ltd (IIL), part of the National Dairy Development Board, is setting up a...
- Indian Immunologicals Ltd produces 1 bn doses of Foot and Mouth disease vaccine
Indian Immunologicals Ltd, a wholly owned subsidiary of NDDB, has produced one billion doses of the Foot and Mouth Disease Vaccine.
- Indian Immunologicals to launch 4 vaccines in a year
Indian Immunologicals Ltd, a subsidiary of National Dairy Development Board, today said it will launch four vaccines in the next one year a...